Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Prostate Specific Antigen Levels of Individuals Living in Rural Areas
A clinical trial sponsored by Suleyman Demirel University examines prostate-specific antigen levels in individuals with prostate cancer livi…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture [NA]
Clinical trial update on using PSMA PET/MR imaging in prostate cancer patients; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Observational Study on Extreme Hypofractionation for Localized Prostate Cancer
An observational trial evaluating extreme hypofractionation using SBRT for localized prostate cancer is currently recruiting, sponsored by U…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Whole Body MRI in Oncology
This clinical trial update describes a study evaluating whole-body MRI in oncology across multiple cancer types, currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: Needle Localization During Prostate Brachytherapy Using Power Doppler Ultrasound [NA]
Clinical trial evaluating needle localization during prostate brachytherapy using Power Doppler ultrasound. The study is currently recruitin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Prophylactic Prostatectomy for Prostate Cancer (PPPC)
This entry reports an ongoing clinical trial (PPPC) evaluating prophylactic prostatectomy for individuals with prostate cancer or genetic pr…
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA [NA]
A completed clinical trial assessing Copper-64 TP3805 PET imaging for detecting prostate cancer in patients with persistently elevated PSA. …
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: An Observational Study of Radiotherapy After Injection of SpaceOAR Hydrogel
An observational study evaluating radiotherapy outcomes after injection of SpaceOAR hydrogel to protect the rectum in prostate cancer; resul…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects? [NA]
This clinical trial from University Hospital Padova is testing whether needle size in transperineal MRI-guided prostate biopsies affects can…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Genomics and Efficacy of Post-prostatectomy Salvage Radiotherapy With 'Extreme' Hypofractionation
This document reports on an ongoing clinical trial evaluating genomics and the efficacy of extreme hypofractionation post-prostatectomy salv…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA [NA]
This clinical trial update notes the study of grape seed extract in asymptomatic non-metastatic prostate cancer patients with rising PSA has…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer [NA]
A completed clinical trial evaluating a novel surgery for prostate cancer has posted results.
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Feasibility of Day-surgery Management for Patients Undergoing Robotic Radical Prostatectomy: a Randomized Trial [NA]
A randomized trial evaluating the feasibility of day-surgery management for patients undergoing robotic radical prostatectomy in prostate ca…
-
FDA approval · 2025-03-21FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for XTANDI (enzalutamide) submitted by Astellas Pharma US, resulting in updated labeling and/or …
-
FDA approval · 2025-03-21FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for XTANDI (enzalutamide) from Astellas Pharma US, Inc. The action updates the product's approved us…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Cytoreductive Prostatectomy Versus Cytoreductive Prostate Irradiation As a Local Treatment Option for Metastatic Prostate Cancer: a Multicentric Feasibility Trial [Phase 2]
A multicenter Phase 2 feasibility trial comparing cytoreductive prostatectomy versus cytoreductive prostate irradiation as local treatments …
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents. [Phase 2]
Phase 2 clinical trial evaluating a novel approach to alleviate the side effects of chemotherapeutic agents in cancer patients. The study in…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Osteosclerotic Changes on CT Predict Survival in Prostate Cancer
New trial results show that osteosclerotic changes on CT scans correlate with survival in patients with prostate cancer, including those wit…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer [Phase 1]
A Phase 1 clinical trial is evaluating 225Ac-PSMA-617 in men with PSMA-positive prostate cancer, including castration-resistant cases; the s…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients [NA]
A single-center prospective interventional trial investigating FPG500 for non-metastatic prostate cancer is registered and currently NOT_YET…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy) [Phase 1, Phase 2]
The PRO-MERIT trial, a Phase 1/2 prostate cancer messenger RNA immunotherapy developed by BioNTech, has been terminated with results posted …
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy [Phase 3]
Phase 3 trial investigating the impact of hormonal therapy on recurrence after radical prostatectomy in prostate cancer is currently recruit…
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer [Phase 3]
This entry describes a Phase 3 clinical trial comparing salvage radiotherapy with individualized PSMA PET/CT–targeted treatment for relapsin…
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer
This entry updates a clinical trial (NCT00769223) investigating predictors of failure after radiation therapy in localized prostate cancer. …
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Prostate Irreversible Electroporation Study [NA]
Update on a prostate cancer trial assessing irreversible electroporation; the study is not yet recruiting.